Thoracic Pathology: A Volume in the High Yield Pathology Series 1st Edition

Acute Cellular Rejection of the Heart

Definition

• Acute cellular rejection occurs from days to years after transplantation and is characterized by infiltrates of activated lymphocytes, macrophages, and occasional eosinophils

Clinical features

Epidemiology

• Can occur at any time from days to months or years after transplantation

• At least 80% of patients experience at least one episode of rejection

Presentation

• Usually asymptomatic because patients are given a diagnosis at time of biopsy

• Only approximately 5% of patients exhibit severe hemodynamic compromise

Prognosis and treatment

• Treatment varies and may include oral and intravenous corticosteroids, antithymocyte globulin, and/or murine monoclonal antibody OKT-3

• Most patients recover from acute rejection

• Repeated episodes of acute rejection increase the risk of accelerated graft vasculopathy

Pathology

Histology

• Endomyocardial biopsies are graded using the International Society of Lung and Heart Transplantation nomenclature published in 1990 and revised in 2005. A comparison of the two grading systems is provided in Web Table 5on the Expert Consult website

• Focal mild rejection (G1A/G1R):

• Focal perivascular interstitial infiltrate consisting of activated lymphocytes

• Infiltrates usually seen in one level or become smaller on subsequent levels

• Diffuse mild rejection (G1B/G1R):

• Few activated lymphocytes between myocytes with no eosinophils or muscle damage

• Focal moderate rejection (G2/G1R):

• Can be single infiltrates often containing eosinophils and macrophages and few plasma cells with focal myocyte damage

• Multifocal moderate rejection (G3A/G2R):

• Two or more foci of infiltrate with associated myocyte damage

• Severe rejection (G3B and G4/G3R):

• Rarely seen with current regimens and is manifested by diffuse aggressive infiltrates (lymphocytes, eosinophils, and neutrophils) with myocyte necrosis and damage

Immunopathology/special stains

• To exclude a Quilty lesion, an immunostain for CD21 can be helpful. CD21 stain is positive in the center of large Quilty lesions and is negative in rejection

Main Differential Diagnoses

• Infection: mixed inflammatory infiltrates

• Quilty effect: is an endocardial infiltrate that is not associated with acute cellular rejection and often infiltrates into the underlying myocardium

• Site of previous biopsy:

• Often seen in the first months after transplantation

• Caused by the fact that biopsy catheter tracks to same region

• Organizing fibrin and granulation tissue

• Reactive endothelial cells and macrophages

• Rare inflammatory cells present

• Later stages demonstrate fibrosis

image

Fig 1 Acute cellular rejection of the heart. This low-power view show an essentially normal endomyocardial biopsy with no cellular infiltrates (grade G0).

image

Fig 2 Acute cellular rejection of the heart. This low-power view show a small focus of perivascular interstitial infiltrate consisting of activated lymphocytes (grade G1A/1R).

image

Fig 3 Acute cellular rejection of the heart. This high-power view shows an interstitial infiltrate consisting of few activated lymphocytes between myocytes with no eosinophils or muscle damage (grade G1B/1R).

image

Fig 4 Acute cellular rejection of the heart. This medium-power view shows an area of lymphocytic infiltrate with associated muscle damage (grade G2/1R).

image

Fig 5 Acute cellular rejection of the heart. There are extensive interstitial lymphoid infiltrates (grade 3B/3R) with associated muscle damage: low (A) and high (B) powers.

image

Fig 6 Acute cellular rejection of the heart. Site of previous biopsy with organizing fibrin and few inflammatory cells.

WEB TABLE 5 Comparison of 1990 and 2005 Heart Rejection Grading Formulations

DESCRIPTION OF REJECTION

1990 GRADE

2005 GRADE

Focal mild, mild and focal moderate

1A, 1B, 2

1R

Multifocal moderate

3A

2R

Diffuse moderate, severe

3B, 4

3R



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!